The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial
The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial
The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial
Budi Setiawan, Ignatius Riwanto, Rahajuningsih Dharma Setiabudy, Eko Adhi Pangarsa, Widi Budianto, Aru Wisaksono Sudoyo, Damai Santosa, Tri Indah Winarni, Tri Wahyu Sukarnowati, Daniel Rizky, Catharina Suharti
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Thrombosis JournalVol. 23(1)
Institutions
Diponegoro University (ID), Dr. Kariadi Hospital (ID), University of Indonesia (ID), Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (ID)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
The efficacy of atorvastatin on inflammation and coagulation markers in high-risk thrombotic cancer patients undergoing chemotherapy: a randomized controlled trial — Budi Setiawan, Ignatius Riwanto, et al. · Thrombosis Journal (2025) | TGRS Research Map | TGRS